FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308496131> ?p ?o ?g. }

• W4308496131 abstract "Abstract Background The aim of this study was to describe changes in patient-reported functional outcome measures (PROMs) comparing pre-treatment and 12 months after radical prostatectomy (RP), external beam radiation therapy (EBRT), brachytherapy and active surveillance (AS). Methods Men enrolled from 2010 to 2019 in the South Australian Prostate Cancer Clinical Outcomes Collaborative registry a prospective clinical registry were studied. Urinary, bowel, and sexual functions were measured using Expanded Prostate Cancer Index Composite (EPIC-26) at baseline and 12 months post-treatment. Higher scores on the EPIC-26 indicate better function. Multivariable regression models were applied to compare differences in function and extent of bother by treatment. Results Of the 4926 eligible men, 57.0% underwent RP, 20.5% EBRT, 7.0% brachytherapy and 15.5% AS. While baseline urinary and bowel function varied little across treatment groups, sexual function differed greatly (adjusted mean scores: RP = 56.3, EBRT = 45.8, brachytherapy = 61.4, AS = 52.8; p < 0.001). Post-treatment urinary continence and sexual function declined in all treatment groups, with the greatest decline for sexual function after RP (adjusted mean score change − 28.9). After adjustment for baseline differences, post-treatment sexual function scores after EBRT (6.4; 95%CI, 0.9–12.0) and brachytherapy (17.4; 95%CI, 9.4–25.5) were higher than after RP. Likewise, urinary continence after EBRT (13.6; 95%CI, 9.0-18.2), brachytherapy (10.6; 95%CI, 3.9–17.3) and AS (10.6; 95%CI, 5.9–15.3) were higher than after RP. Conversely, EBRT was associated with lower bowel function (− 7.9; 95%CI, − 12.4 to − 3.5) than RP. EBRT and AS were associated with lower odds of sexual bother (OR 0.51; 95%CI, 0.29–0.89 and OR 0.60; 95%CI, 0.38–0.96, respectively), and EBRT with higher odds of bowel bother (OR 2.01; 95%CI, 1.23–3.29) compared with RP. Conclusion The four common treatment approaches for prostate cancer were associated with different patterns of patient-reported functional outcomes, both pre- and 12 months post-treatment. However, after adjustment, RP was associated with a greater decline in urinary continence and sexual function than other treatments. This study underscores the importance of collecting baseline PROMs to interpret post-treatment functional outcomes." @default.
• W4308496131 created "2022-11-12" @default.
• W4308496131 creator A5004284053 @default.
• W4308496131 creator A5007267303 @default.
• W4308496131 creator A5011232720 @default.
• W4308496131 creator A5013333982 @default.
• W4308496131 creator A5017833700 @default.
• W4308496131 creator A5053611269 @default.
• W4308496131 creator A5074950235 @default.
• W4308496131 creator A5079023861 @default.
• W4308496131 creator A5082576378 @default.
• W4308496131 date "2022-11-05" @default.
• W4308496131 modified "2023-10-18" @default.
• W4308496131 title "Patient-reported functional outcome measures and treatment choice for prostate cancer" @default.
• W4308496131 cites W1966397853 @default.
• W4308496131 cites W1968185435 @default.
• W4308496131 cites W1968400906 @default.
• W4308496131 cites W2017622807 @default.
• W4308496131 cites W2025824469 @default.
• W4308496131 cites W2040008722 @default.
• W4308496131 cites W2101972593 @default.
• W4308496131 cites W2137282952 @default.
• W4308496131 cites W2364135209 @default.
• W4308496131 cites W2519027667 @default.
• W4308496131 cites W2601864730 @default.
• W4308496131 cites W2603592198 @default.
• W4308496131 cites W2605357195 @default.
• W4308496131 cites W2625871730 @default.
• W4308496131 cites W2740573178 @default.
• W4308496131 cites W2765277639 @default.
• W4308496131 cites W2795762275 @default.
• W4308496131 cites W2906163483 @default.
• W4308496131 cites W2944127154 @default.
• W4308496131 cites W2945522282 @default.
• W4308496131 cites W2964766379 @default.
• W4308496131 cites W2991064119 @default.
• W4308496131 cites W2999081098 @default.
• W4308496131 cites W3006615740 @default.
• W4308496131 cites W3015026435 @default.
• W4308496131 cites W3016928995 @default.
• W4308496131 cites W3125115818 @default.
• W4308496131 cites W3126472823 @default.
• W4308496131 doi "https://doi.org/10.1186/s12894-022-01117-1" @default.
• W4308496131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36335325" @default.
• W4308496131 hasPublicationYear "2022" @default.
• W4308496131 type Work @default.
• W4308496131 citedByCount "2" @default.
• W4308496131 countsByYear W43084961312023 @default.
• W4308496131 crossrefType "journal-article" @default.
• W4308496131 hasAuthorship W4308496131A5004284053 @default.
• W4308496131 hasAuthorship W4308496131A5007267303 @default.
• W4308496131 hasAuthorship W4308496131A5011232720 @default.
• W4308496131 hasAuthorship W4308496131A5013333982 @default.
• W4308496131 hasAuthorship W4308496131A5017833700 @default.
• W4308496131 hasAuthorship W4308496131A5053611269 @default.
• W4308496131 hasAuthorship W4308496131A5074950235 @default.
• W4308496131 hasAuthorship W4308496131A5079023861 @default.
• W4308496131 hasAuthorship W4308496131A5082576378 @default.
• W4308496131 hasBestOaLocation W43084961311 @default.
• W4308496131 hasConcept C121608353 @default.
• W4308496131 hasConcept C126322002 @default.
• W4308496131 hasConcept C126894567 @default.
• W4308496131 hasConcept C188816634 @default.
• W4308496131 hasConcept C2775871022 @default.
• W4308496131 hasConcept C2775908122 @default.
• W4308496131 hasConcept C2777416452 @default.
• W4308496131 hasConcept C2779466945 @default.
• W4308496131 hasConcept C2780192828 @default.
• W4308496131 hasConcept C2993211783 @default.
• W4308496131 hasConcept C509974204 @default.
• W4308496131 hasConcept C71924100 @default.
• W4308496131 hasConceptScore W4308496131C121608353 @default.
• W4308496131 hasConceptScore W4308496131C126322002 @default.
• W4308496131 hasConceptScore W4308496131C126894567 @default.
• W4308496131 hasConceptScore W4308496131C188816634 @default.
• W4308496131 hasConceptScore W4308496131C2775871022 @default.
• W4308496131 hasConceptScore W4308496131C2775908122 @default.
• W4308496131 hasConceptScore W4308496131C2777416452 @default.
• W4308496131 hasConceptScore W4308496131C2779466945 @default.
• W4308496131 hasConceptScore W4308496131C2780192828 @default.
• W4308496131 hasConceptScore W4308496131C2993211783 @default.
• W4308496131 hasConceptScore W4308496131C509974204 @default.
• W4308496131 hasConceptScore W4308496131C71924100 @default.
• W4308496131 hasFunder F4320311494 @default.
• W4308496131 hasIssue "1" @default.
• W4308496131 hasLocation W43084961311 @default.
• W4308496131 hasLocation W43084961312 @default.
• W4308496131 hasLocation W43084961313 @default.
• W4308496131 hasLocation W43084961314 @default.
• W4308496131 hasLocation W43084961315 @default.
• W4308496131 hasOpenAccess W4308496131 @default.
• W4308496131 hasPrimaryLocation W43084961311 @default.
• W4308496131 hasRelatedWork W2003364719 @default.
• W4308496131 hasRelatedWork W2061363996 @default.
• W4308496131 hasRelatedWork W2071879586 @default.
• W4308496131 hasRelatedWork W2120703505 @default.
• W4308496131 hasRelatedWork W2123312949 @default.
• W4308496131 hasRelatedWork W2124773766 @default.
• W4308496131 hasRelatedWork W3132851114 @default.
• W4308496131 hasRelatedWork W4206581437 @default.

• next